Trademarks / Class 44 / XCELLSENSE

XCELLSENSE

SN 99093360 REG 8318526Principal RegisterUSPTO TSDR ↗
Live · Registered LIVE/REGISTRATION/Issued and Active
Mark · Service Mark
XCELLSENSE - official mark drawing from the USPTO record

What this record means

The record shows that the mark “XCELLSENSE” is live and registered on the Principal Register, owned by ImpriMed, Inc., a Delaware corporation. The registration covers a broad range of medical and beauty services, including diagnostic, testing, analysis, and clinical data analytics for human and animal health, as well as cultured‑cell treatment and cancer diagnosis. A similar name used in these or closely related medical services would raise the closest record‑based concern. The record does not grant control over every use of the wording, especially outside the listed services. The prosecution history indicates a smooth path to registration with no opposition or enforcement actions recorded. The most recent event is the notice of registration confirmation on June 23, 2026, and the next significant date is the maintenance deadline in 2028, though it is not supplied here. For someone considering a similar name, the presence of an active Principal Register registration in medical services suggests a meaningful risk of conflict in that field.

Informational only - not legal advice.

Mark Service Mark

XCELLSENSE
Standard-character drawing · USPTO TSDR, retrieved Sep 18, 2026
Drawing type4 - STANDARD CHARACTER MARK
Filing basisUse in Commerce (§1(a)).
StatusRegistered. The registration date is used to determine when post-registration maintenance documents are due.

Key dates

Application filedMar 19, 2025
Published for oppositionDec 02, 2025
Notice of AllowanceJan 27, 2026
Registered (Principal)Jun 23, 2026
Status dateJun 23, 2026

Goods & services

Cl. 044Medical & Beauty ServicesACTIVE

Medical diagnostic services; medical testing services; medical analysis services relating to the treatment of persons; medical testing for diagnostic or treatment purposes; medical analysis services for diagnostic and treatment purposes; Medical and medical clinical diagnostic testing, monitoring and reporting services related to in vitro testing for medical and pharmaceutical use; medical treatment using cultured cells; medical analysis services for cancer diagnosis and prognosis; Providing medical and medical clinical data analytics and bioinformatics services; medical analysis services for the diagnosis of cancer and other diseases in human and animals; health care services, namely, providing medical information in the field of cancer and other human and animal diseases via a database, all for treatment and diagnostic purposes; providing medical and paramedical information via a website and online portal; providing information and advice in the field of pet health; health care information services in the fields of medical, health, and clinical care; veterinary specialty services providing advanced medical, diagnostic or surgical services for animals.

First use: Mar 26, 2025
Use in commerce: Mar 26, 2025

Madrid Protocol · §66(a)

Intl. registration no.1857486

Owner & representation

OwnerImpriMed, Inc.
Address1130 Independence Ave, Mountain View, CALIFORNIA UNITED STATES 94043
EntityCORPORATION - organized in DELAWARE
Attorney of recordBeatrice Martinet
CorrespondentBeatrice Martinet
Attorney emailt********@*****.com
Correspondent email3 emails
Correspondent phone1********0
Correspondent addressSan Francisco, CALIFORNIA
Full details in the report

Prosecution history 3 of 29 events

Jun 23, 2026
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 23, 2026
REGISTERED-PRINCIPAL REGISTER
Jun 03, 2026
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
🔒 Full timeline (29 events) in the report

Ask about this record ✦ AI

Your name deserves a straight answer.

Search the federal register free. No account, no caps, no waiting around.

Run a free trademark search